Author:
Mounien Lourdes,Do Rego Jean-Claude,Bizet Patrice,Boutelet Isabelle,Gourcerol Guillaume,Fournier Alain,Brabet Philippe,Costentin Jean,Vaudry Hubert,Jégou Sylvie
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference57 articles.
1. Banks WA, Kastin AJ, Komaki G, Arimura A (1993). Passage of pituitary adenylate cyclase activating polypeptide 1–27 and pituitary adenylate cyclase activating polypeptide 1–38 across the blood brain barrier. J Pharmacol Exp Ther 267: 690–696.
2. Berthoud HR (2002). Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 26: 393–428.
3. Birk S, Sitarz JT, Petersen KA, Oturai PS, Kruuse C, Fahrenkrug J et al (2007). The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept 140: 185–191.
4. Borba JC, Henze IP, Silveira MS, Kubrusly RC, Gardino PF, de Mello MC et al (2005). Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Brain Res Dev 156: 193–201.
5. Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H et al (2008). Novel stable PACAP analogs with potent activity toward the PAC1 receptor. Peptides 29: 919–932.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献